🔴 HCW Biologics is trading 7.35% down today as the cause remains unclear

HCW Biologics is trading 7.35% down at $2.71, with no confirmed company-specific catalyst identified.

• The stock declined from $2.92 on August 13, 2026.
• No confirmed announcement or catalyst was identified for August 14, 2026; the investor-relations feed shows its latest release as the July 29 private-placement announcement.
• Broader markets are modestly weaker, but S&P 500 and Nasdaq declines remain below 0.5%; the cause therefore remains unclear.